Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center, Randomized,Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy Study of Tavilermide Ophthalmic Solutions for the Treatment of Dry Eye

NCT03925727 is registered in ClinicalTrials.gov with Mimetogen Pharmaceuticals USA, Inc. as lead sponsor.

NCT NCT03925727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03925727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center, Randomized,Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy Study of Tavilermide Ophthalmic Solutions for the Treatment of Dry Eye
Lead sponsor
Mimetogen Pharmaceuticals USA, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 28, 2019
Completion date
June 11, 2020
Enrollment
623 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, keratoconjunctivitis sicca